Zymeworks Share Price

Zymeworks Share Price

NASDAQ: ZYME | Mid Cap | Healthcare
$26.86
+$0.82 (3.15%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Zymeworks Stock Performance

Open
$26.02
Prev. Close
$26.04
Circuit Range
N/A
Day Range
$25.95 - $27.43
Year Range
$21.68 - $31.92
Volume
48,005
Average Traded
$26.89

Zymeworks Share Price Today

As of 20 November 2026, Zymeworks Inc.'s share price is $26.86. The stock opened at $26.02, compared to its previous close of $26.04. During today's trading session, Zymeworks Inc.'s share price traded between $25.95 and $27.43, with an average price of $26.69. Over the past 52 weeks, the stock has recorded a high of $31.92 and a low of $21.68. In terms of performance, Zymeworks Inc.'s share price has risen by 6.95% over the last six months and is up 0.45% on a year-on-year basis.

Zymeworks Share Price Chart

Line chart of the Zymeworks price trend over the selected period. The price rose overall, ranging from 24.92 to 26.23, ending at 26.04.
$25.95$27.43
L
Show Current Price
H

Zymeworks Stock Fundamentals & Key Indicators

Market Cap
$2.03B
PE Ratio (TTM)
42.16
Dividend Yield
0.00%
EPS (TTM)
$0.62
Revenue (TTM)
$105.97B
Return On Equity (TTM)
16.77%
Profit Margin
-76.56%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
521.50%

Zymeworks Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$2.52$2.41$4.59$256.46
Net Profit-$41.21-$44.16-$45.02$173.70
Net Profit Margin-1635.32%-1832.37%-980.83%67.73%
Income ChangeN/A-7.16%-1.95%485.83%

Zymeworks Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$412.48$76.01$76.30$105.97
Net Profit$124.34-$118.67-$122.70-$81.13
Net Profit Margin30.14%-156.12%-160.81%-76.56%
Income ChangeN/A-195.44%-3.40%33.88%

Zymeworks Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets97.76162.64167.95104.02
Current Assets248.77300.45412.93544.71
Total Assets346.53463.09580.88648.73
Non Current Liabilities35.7136.0360.3160.14
Current Liabilities42.3288.2955.7695.63
Total Liabilities78.03124.32116.07155.77
Shareholders' Equity268.5338.77464.81492.96

Zymeworks Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-33.01-110.06-118.32144.11
Investing26.6638.76-207.25-53.85
Financing-18.56-20.4481.87108.58

About Zymeworks

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Zymeworks Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$28.89
$26.88
-5.95%
Oct 2026
$26.43
$28.58
+7.81%
Sep 2026
$29.07
$26.51
-8.57%
Aug 2026
$22.02
$29.00
+32.04%
Jul 2026
$26.18
$21.96
-16.45%
Jun 2026
$24.84
$26.29
+4.66%
May 2026
$26.97
$25.11
-8.92%
Apr 2026
$25.04
$27.57
+10.17%
Mar 2026
$22.91
$25.03
+7.29%
Feb 2026
$22.70
$23.33
+3.46%
Jan 2026
$26.04
$22.55
-14.39%
Dec 2025
$26.29
$26.34
-1.50%

Zymeworks Share Price FAQs